Sanofi

-

Stock Issuer and Owners

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
Latest Filings
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Sanofi
TickerSNY
CIK #0001121404
CUSIP80105N105
SectorLife Sciences - Pharmaceutical Preparations
Address54 Rue La Boetie, Paris, 75008
Source [EDGAR]
CIK Filing 2011 - 2024
[0001121404] 3
[0001121404] 4
[0001121404] 6-K
[0001121404] SC 13D
[0001121404] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Dodge & Cox Sanofi [2022-02-14] 5.6
Sanofi Icosavax Inc [2022-02-08] 8.08
Sanofi Translate Bio Inc [2021-08-12] 4.9
Sanofi LAVA Therapeutics NV [2021-03-31] 7.0
Amundi Sanofi [2021-02-16] 5.0
Sanofi Revolution Medicines Inc [2021-02-11] 4.6
Sanofi Translate Bio Inc [2021-02-04] 6.6
Sanofi Fulcrum Therapeutics Inc [2019-07-29] 2.4
Sanofi UNUM Therapeutics Inc [2019-02-11] 5.91
Sanofi Ablynx NV [2018-05-25] 5.6
Sanofi Myokardia Inc [2016-02-12] 11.9
Sanofi Voyager Therapeutics Inc [2016-02-12] 0.3
BlackRock Inc Sanofi [2016-02-09] 5.5
Sanofi Immune Design Corp [2014-08-01] 5.8
Sanofi Immune Design Corp [2014-07-31] 5.8
Sanofi Scynexis Inc [2014-05-09] 19.27
Sanofi Alnylam Pharmaceuticals Inc [2014-03-05] 12.0
Sanofi Regeneron Pharmaceuticals Inc [2014-01-14] 16.24
Sanofi Regulus Therapeutics Inc [2012-10-09] 10.99
Sanofi Merrimack Pharmaceuticals Inc [2012-04-02] 5.65
Total Sa Sanofi [2012-02-14] 3.22
Form 3/4/5 Filer 2011 - 2024
Translate Bio, Inc.
Sanofi
Icosavax, Inc.
Inozyme Pharma, Inc.
Regeneron Pharmaceuticals Inc
Fulcrum Therapeutics, Inc.
MyoKardia, Inc.
Alnylam Pharmaceuticals Inc
Voyager Therapeutics, Inc.
Scynexis Inc
Regulus Therapeutics Inc.
Glycomimetics Inc
Humanigen Inc
Form 13F Holdings
Firm Period DFND Voting Shares
Dodge & Cox [2023-03-31] SOLE 78,535,895.0 82,517,326.0
FMR LLC [2023-03-31] DFND 15,323,132.0 23,282,201.0
Boston Partners [2023-03-31] DFND 13,512,290.0 14,314,227.0
Fisher Asset Management LLC [2023-03-31] DFND 13,203,736.0 13,359,529.0
Bank of America Corp /DE/ [2023-03-31] DFND 101,452.0 10,626,939.0
BlackRock Inc. [2023-03-31] SOLE 9,818,325.0 10,047,856.0
Morgan Stanley [2023-03-31] DFND 5,925,949.0 7,890,643.0
Invesco Ltd. [2023-03-31] DFND 0.0 6,548,335.0
Envestnet Asset Management Inc [2023-03-31] SOLE 5,747,192.0 5,747,192.0
Camber Capital Management LP [2023-03-31] SOLE 5,500,000.0 5,500,000.0
Bank of New York Mellon Corp [2023-03-31] DFND 5,130,647.0 5,172,766.0
Boston Partners [2023-03-31] OTR 903,965.0 3,631,716.0
Nuveen Asset Management LLC [2023-03-31] DFND 3,058,946.0 3,058,946.0
Millennium Management LLC [2023-03-31] SOLE 2,286,104.0 2,891,304.0
Goldman Sachs Group Inc [2023-03-31] DFND 1,906,015.0 2,644,149.0
Adage Capital Partners GP LLC [2023-03-31] SOLE 2,634,256.0 2,634,256.0
Hotchkis & Wiley Capital Management LLC [2023-03-31] SOLE 2,230,626.0 2,373,925.0
Arrowstreet Capital Limited Partnership [2023-03-31] DFND 1,807,016.0 2,336,852.0
Wells Fargo & Company/MN [2023-03-31] DFND 213,451.0 2,328,820.0
Federated Hermes Inc [2023-03-31] DFND 1,998,853.0 2,101,749.0
Royal Bank of Canada [2023-03-31] DFND 1,525,544.0 2,064,576.0
Price T Rowe Associates Inc /MD/ [2023-03-31] SOLE 1,162,381.0 2,042,680.0
Equity Investment Corp [2023-03-31] SOLE 1,793,885.0 2,008,448.0
Natixis Advisors LP [2023-03-31] DFND 1,973,531.0 1,973,531.0
JPMorgan Chase & Co [2023-03-31] DFND 216,849.0 1,876,819.0
Raymond James & Associates [2023-03-31] SOLE 1,618,188.0 1,756,016.0
Pictet Asset Management Sa [2023-03-31] DFND 0.0 1,495,012.0
American Century Companies Inc [2023-03-31] DFND 1,428,009.0 1,483,609.0
First Trust Advisors LP [2023-03-31] SOLE 1,386,165.0 1,386,257.0
Mondrian Investment Partners LTD [2023-03-31] SOLE 0.0 1,301,169.0
Prev | Page 1 | Next
Terms | Privacy | Guide
tony@aum13f.com